The effect of therapeutic drug monitoring of risperidone and aripiprazole on weight gain in children and adolescents: the SPACe 2: STAR (trial) protocol of an international multicentre randomised controlled trial.

Rebecca A HermansLisa T RingelingKajie LiangSanne M KloosterboerBrenda C M de WinterManon H J HillegersBirgit C P KochBram Dierckx

Published in: BMC psychiatry (2022)

ClinicalTrials.gov Identifier: NCT05146245. EudraCT number: 2020-005450-18. Sponsor protocol name: SPACe2STAR. Registered 8 June 2021. Protocol Version 6, Protocol date: 18 august 2022.

Keyphrases

weight gain
randomized controlled trial
study protocol
body mass index
clinical trial
birth weight
phase ii